JP2016064151A5 - - Google Patents

Download PDF

Info

Publication number
JP2016064151A5
JP2016064151A5 JP2015239881A JP2015239881A JP2016064151A5 JP 2016064151 A5 JP2016064151 A5 JP 2016064151A5 JP 2015239881 A JP2015239881 A JP 2015239881A JP 2015239881 A JP2015239881 A JP 2015239881A JP 2016064151 A5 JP2016064151 A5 JP 2016064151A5
Authority
JP
Japan
Prior art keywords
vagus nerve
branch
electrical signal
programmable
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015239881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016064151A (ja
JP6140258B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016064151A publication Critical patent/JP2016064151A/ja
Publication of JP2016064151A5 publication Critical patent/JP2016064151A5/ja
Application granted granted Critical
Publication of JP6140258B2 publication Critical patent/JP6140258B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015239881A 2008-04-04 2015-12-09 糖調節のための方法およびシステム Expired - Fee Related JP6140258B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4257508P 2008-04-04 2008-04-04
US61/042,575 2008-04-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013268765A Division JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016247977A Division JP2017051810A (ja) 2008-04-04 2016-12-21 糖調節のための方法およびシステム

Publications (3)

Publication Number Publication Date
JP2016064151A JP2016064151A (ja) 2016-04-28
JP2016064151A5 true JP2016064151A5 (enExample) 2016-07-07
JP6140258B2 JP6140258B2 (ja) 2017-05-31

Family

ID=40718529

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011503199A Expired - Fee Related JP5486588B2 (ja) 2008-04-04 2009-04-03 糖調節のための方法およびシステム
JP2013268765A Expired - Fee Related JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム
JP2015239881A Expired - Fee Related JP6140258B2 (ja) 2008-04-04 2015-12-09 糖調節のための方法およびシステム
JP2016247977A Withdrawn JP2017051810A (ja) 2008-04-04 2016-12-21 糖調節のための方法およびシステム

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2011503199A Expired - Fee Related JP5486588B2 (ja) 2008-04-04 2009-04-03 糖調節のための方法およびシステム
JP2013268765A Expired - Fee Related JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016247977A Withdrawn JP2017051810A (ja) 2008-04-04 2016-12-21 糖調節のための方法およびシステム

Country Status (7)

Country Link
US (5) US8483830B2 (enExample)
EP (2) EP2300099A1 (enExample)
JP (4) JP5486588B2 (enExample)
CN (2) CN102056645B (enExample)
AU (1) AU2009231601B2 (enExample)
HK (1) HK1217306A1 (enExample)
WO (1) WO2009124233A1 (enExample)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
JP5351884B2 (ja) 2007-04-23 2013-11-27 インターシア セラピューティクス，インコーポレイティド インスリン分泌促進性ペプチドの懸濁製剤及び使用
WO2009029614A1 (en) * 2007-08-27 2009-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
WO2009124233A1 (en) * 2008-04-04 2009-10-08 Enteromedics, Inc. Methods and systems for glucose regulation
WO2010006341A1 (en) * 2008-07-11 2010-01-14 Gep Technology, Inc. Apparatus and methods for minimally invasive obesity treatment
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US8412338B2 (en) 2008-11-18 2013-04-02 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
CA2758944C (en) 2009-04-22 2023-03-14 Konstantinos Alataris Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US8996116B2 (en) * 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (en) 2009-06-09 2018-09-12 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
WO2011079309A2 (en) 2009-12-23 2011-06-30 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8825164B2 (en) 2010-06-11 2014-09-02 Enteromedics Inc. Neural modulation devices and methods
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103619405B (zh) 2011-05-09 2015-11-25 赛博恩特医疗器械公司 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
CN107080561B (zh) 2011-12-09 2020-09-11 麦特文申公司 用于神经调节的设备、系统和方法
US20130237948A1 (en) * 2012-03-07 2013-09-12 Enteromedics, Inc. Devices for regulation of blood pressure and heart rate
US20150111918A1 (en) 2012-03-08 2015-04-23 Medtronic Ardian Luxembourg S.a.r.l Immune system neuromodulation and associated systems and methods
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9254099B2 (en) 2013-05-23 2016-02-09 Medibotics Llc Smart watch and food-imaging member for monitoring food consumption
US9536449B2 (en) 2013-05-23 2017-01-03 Medibotics Llc Smart watch and food utensil for monitoring food consumption
US9442100B2 (en) 2013-12-18 2016-09-13 Medibotics Llc Caloric intake measuring system using spectroscopic and 3D imaging analysis
US9042596B2 (en) 2012-06-14 2015-05-26 Medibotics Llc Willpower watch (TM)—a wearable food consumption monitor
US8504161B1 (en) * 2012-08-07 2013-08-06 Medtronic, Inc. Modulate vagal signals to reduce inflammation
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US9526834B2 (en) 2012-08-30 2016-12-27 Medtronic Minimed, Inc. Safeguarding measures for a closed-loop insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
AU2013309344B2 (en) * 2012-08-30 2018-11-08 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
CN108159564A (zh) * 2013-01-28 2018-06-15 重塑生命科学股份有限公司 把疗法施加于患者靶神经的系统
US9529385B2 (en) 2013-05-23 2016-12-27 Medibotics Llc Smart watch and human-to-computer interface for monitoring food consumption
CN105473089A (zh) 2013-06-05 2016-04-06 麦特文申公司 靶标神经纤维的调节
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
WO2015039108A2 (en) 2013-09-16 2015-03-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-element coupler for generation of electromagnetic energy
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
WO2015179225A1 (en) 2014-05-18 2015-11-26 Yeh Alexander Jueshyan Midfield coupler
US20160336813A1 (en) 2015-05-15 2016-11-17 NeuSpera Medical Inc. Midfield coupler
CN104147699A (zh) * 2014-07-31 2014-11-19 李军 一种用于治疗2型糖尿病的腹腔神经丛电刺激系统
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
EP4085970A1 (en) * 2014-11-03 2022-11-09 Presidio Medical, Inc. Neuromodulation device
WO2016090175A1 (en) 2014-12-03 2016-06-09 Metavention, Inc. Systems and methods for modulating nerves or other tissue
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
CA2977224A1 (en) 2015-02-20 2016-08-25 The Feinstein Institute For Medical Research Nerve stimulation for treatment of diseases and disorders
US9872985B2 (en) 2015-03-03 2018-01-23 Georgia Tech Research Corporation Glucose regulation via electrical stimulation of nerves innervating the liver
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
JP2017000437A (ja) * 2015-06-10 2017-01-05 オリンパス株式会社 心筋再生装置
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
EP3405255A4 (en) 2016-01-20 2019-10-16 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTIVE CHARGING SYSTEMS
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
CN109310865B (zh) 2016-01-25 2022-09-13 内弗洛公司 电刺激治疗充血性心力衰竭，以及相关联的系统和方法
US10981007B2 (en) 2016-05-13 2021-04-20 Georgia Tech Research Corporation Systems, methods, and devices for neuromodulation
SG11201810102SA (en) 2016-05-16 2018-12-28 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
US9955882B2 (en) 2016-08-31 2018-05-01 Medtronic Xomed, Inc. System to monitor neural integrity
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
US11872371B2 (en) 2017-04-20 2024-01-16 The Feinstein Institutes For Medical Research Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
EP3668402B1 (en) 2017-08-14 2024-07-31 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
WO2019173525A1 (en) * 2018-03-09 2019-09-12 General Electric Company Ultrasound neuromodulation techniques
CA3096702A1 (en) 2018-04-12 2019-10-17 Reshape Lifesciences, Inc. Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
US11623091B2 (en) * 2019-02-13 2023-04-11 Avent, Inc. Portable electrical stimulation system and method
EP3952982B1 (en) 2019-04-12 2024-03-27 Setpoint Medical Corporation Vagus nerve stimulation system to treat neurodegenerative disorders
CN110064130A (zh) * 2019-04-17 2019-07-30 上海黎欧生物科技有限公司 一种胆囊起搏器
US20220193414A1 (en) * 2019-04-18 2022-06-23 Reshape Lifesciences, Inc. Methods and systems for neural regulation
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
EP4313273A4 (en) * 2021-04-01 2025-01-22 ReShape Lifesciences, Inc. NEUROMODULATION SYSTEM AND METHOD FOR TREATING A HYPOGLYCEMIC CONDITION
US12444497B2 (en) 2021-05-17 2025-10-14 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation
US20230355987A1 (en) * 2022-05-05 2023-11-09 Medtronic, Inc. Systems and methods for stimulating an anatomical element using an electrode device

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20040249421A1 (en) * 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
IL129032A (en) 1999-03-17 2006-12-31 Moshe Dudai Stomach strap
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
IL153543A0 (en) * 2000-07-20 2003-07-06 Bristol Myers Squibb Co PHARMACEUTICAL COMPOSITIONS CONTAINING A COMPOUND WHICH INHIBITS OR MODULATES PPARdelta (beta) ACTIVITY
US6832114B1 (en) 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US6928320B2 (en) 2001-05-17 2005-08-09 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US20090187230A1 (en) 2001-07-23 2009-07-23 Dilorenzo Daniel J Method and apparatus for programming of autonomic neuromodulation for the treatment of obesity
US7689277B2 (en) * 2002-03-22 2010-03-30 Leptos Biomedical, Inc. Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US7689276B2 (en) 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
US7702386B2 (en) 2002-03-22 2010-04-20 Leptos Biomedical, Inc. Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
EP1551499A1 (en) 2002-10-04 2005-07-13 Microchips, Inc. Medical device for neural stimulation and controlled drug delivery
US7167750B2 (en) 2003-02-03 2007-01-23 Enteromedics, Inc. Obesity treatment with electrically induced vagal down regulation
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7844338B2 (en) 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
US7613515B2 (en) 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
WO2005007232A2 (en) 2003-07-21 2005-01-27 Metacure N.V. Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US7620454B2 (en) 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
JP4943841B2 (ja) * 2003-06-20 2012-05-30 メタキュアー リミティド 障害を治療する上で使用するための胃腸方法及び器具
US20070060971A1 (en) * 2003-07-21 2007-03-15 Ofer Glasberg Hepatic device for treatment or glucose detection
US7711432B2 (en) * 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
US8214047B2 (en) 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
US7603174B2 (en) 2004-10-21 2009-10-13 Advanced Neuromodulation Systems, Inc. Stimulation of the amygdalohippocampal complex to treat neurological conditions
US20060122098A1 (en) * 2004-12-08 2006-06-08 Aoki Thomas T System for infusing insulin to a subject to imporve impaired total body tissue glucose processing
CA2593079C (en) * 2004-12-27 2014-08-19 North Shore-Long Island Jewish Research Institute Treating inflammatory disorders by electrical vagus nerve stimulation
US8260426B2 (en) 2008-01-25 2012-09-04 Cyberonics, Inc. Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
EP1880298B1 (en) 2005-02-17 2016-07-13 Metacure Limited Charger with data transfer capabilities
US7561923B2 (en) 2005-05-09 2009-07-14 Cardiac Pacemakers, Inc. Method and apparatus for controlling autonomic balance using neural stimulation
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US20070027484A1 (en) * 2005-07-28 2007-02-01 Cyberonics, Inc. Autonomic nerve stimulation to treat a pancreatic disorder
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
WO2007058780A2 (en) * 2005-11-10 2007-05-24 Electrocore, Inc. Electrical stimulation treatment of bronchial constriction
US8041428B2 (en) 2006-02-10 2011-10-18 Electrocore Llc Electrical stimulation treatment of hypotension
JP5108787B2 (ja) * 2006-01-23 2012-12-26 リハブトロニクス インコーポレイテッド 埋め込まれた受動導体を介して電流を体組織へルーティングする方法
EP1981584B1 (en) 2006-02-03 2015-05-13 Interventional Autonomics Corporation Intravascular device for neuromodulation
CN101400403A (zh) 2006-02-10 2009-04-01 电子核心公司 利用电调制来治疗过敏反应的方法和装置
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8160709B2 (en) 2006-05-18 2012-04-17 Endostim, Inc. Use of electrical stimulation of the lower esophageal sphincter to modulate lower esophageal sphincter pressure
US8634930B2 (en) 2006-06-30 2014-01-21 Cardiac Pacemakers, Inc. System for providing diabetic therapy
US8068918B2 (en) 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
US20080281365A1 (en) 2007-05-09 2008-11-13 Tweden Katherine S Neural signal duty cycle
US20080300645A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300648A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US8140167B2 (en) 2007-05-31 2012-03-20 Enteromedics, Inc. Implantable therapy system with external component having multiple operating modes
US20080300647A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300646A1 (en) 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US9186502B2 (en) * 2008-02-14 2015-11-17 Enteromedics Inc. Treatment of excess weight by neural downregulation in combination with compositions
WO2009124233A1 (en) 2008-04-04 2009-10-08 Enteromedics, Inc. Methods and systems for glucose regulation
US20090254133A1 (en) 2008-04-07 2009-10-08 Wendell Keith F Method for treatment of diabetes by electrostimulatioin
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US20090275997A1 (en) 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US20100056948A1 (en) 2008-08-26 2010-03-04 Hornby Pamela J Stimulation of Satiety Hormone Release
US20120053653A1 (en) 2009-05-08 2012-03-01 Universite Libre De Bruxelles Gastrointestinal device
US20120259389A1 (en) 2009-09-21 2012-10-11 Warren Starkebaum Treatment of postprandial hyperglycemia by gastric electrical stimulation
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
WO2011150377A2 (en) 2010-05-27 2011-12-01 Ndi Medical, Llc Waveform shapes for treating neurological disorders optimized for energy efficiency
AU2011282294B9 (en) 2010-07-19 2014-09-25 Cardiac Pacemakers, Inc. Minimally invasive lead system for vagus nerve stimulation
WO2012044472A2 (en) 2010-10-01 2012-04-05 Indiana University Research & Technology Corporation Long term vagal nerve stimulation for therapeutic and diagnostic treatment
US9474482B2 (en) 2010-11-01 2016-10-25 G-Tech Medical, Inc. Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith
US9014813B2 (en) 2010-11-03 2015-04-21 Cleveland Clinic Foundation Apparatus for energy efficient stimulation
EP2651431B1 (en) 2010-12-17 2018-03-07 Neural Diabetes LLC System and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production

Similar Documents

Publication Publication Date Title
JP2016064151A5 (enExample)
EP4385558A3 (en) Dynamic control of heart failure therapy
WO2014200739A3 (en) Delivery system with pacing element
WO2011156286A3 (en) Stimulation therapy for bladder dysfunction
WO2011139623A3 (en) System and method for stimulating sensory nerves
MX2019007714A (es) Articulo y metodo para tratar neuropatia diabetica periferica.
WO2012012591A3 (en) Improved use of electric fields for reducing patient discomfort during defibrillation
DE602006021791D1 (de) Vorrichtung zur behandlung von epilepsie und rhythmusstörungen
WO2011156439A3 (en) Neural modulation devices and methods
EP2566571A4 (en) REDUNDANT PACEMAKER SYSTEM WITH GUIDED AND IMMEDIATE STEERING CONTROL
WO2009023543A3 (en) Systems and methods of neuromodulation stimulation for the restoration of sexual function
CA3014317C (en) DEVICE FEATURING ENHANCED STIMULATION WAVEFORMS
WO2012139063A3 (en) Stimulation devices and methods
EP4338792A3 (en) Implantable cardioverter-defibrillator (icd) system including substernal lead
MX367932B (es) Metodo y sistema para monitorear y tratar una afeccion medica a traves de la estimulacion del nervio tibial posterior.
WO2015191886A3 (en) Systems and methods for treating cardiac arrhythmias
AU2017232365A8 (en) Microcurrent device and method for the treatment of visual disease
EP4000680A3 (en) Methods and systems for employing a duty cycle in electrical stimulation of patient tissue
WO2009134350A3 (en) Systems for selectively stimulating nerve roots
WO2011139596A3 (en) Method and device for three-stage atrial cardioversion therapy
EP1824405A4 (en) ABLATION SYSTEM WITH FEEDBACK
GR1006568B (el) Μεθοδος και συστημα για την καταγραφη και υποβοηθηση της αναγεννησης περιφερικου νευρου
RU2007125253A (ru) Способ лечения больных травматической болезнью спинного мозга
NZ711655A (en) Implantable electroacupuncture device employing a high impedance coin-cell battery as a primary power source
NZ737871A (en) Electroporation system for controlled localized therapeutics delivery